Skip to main content

Merck KGaA wins battle for Versum

25th April 2019

Submitted by:

Andrew Warmington

Merck KGaA has signed a definitive agreement to acquire Versum Materials, a US-based producer of electronic materials. The company’s offer, which Versum initially rejected as it pursued a merger with Integris, was accepted after it was raised from $48/share to $53. Versum has now terminated its discussions with Integris.

The deal gives Versum an enterprise value of about €5.8 billion, with a pro forma value of 11.6 x EBITA, including €75 million/year of identified run-rate cost synergies. It is expected to be accretive to reported earnings in the third full year after closing. This is expected to take place in 2H 2019, subject to agreement by Versum shareholders at a special meeting.

Merck CEO and executive board chairman Stefan Oschmann said that the transaction will leave the company “optimally positioned to capitalise on long-term growth trends in the electronic materials industry”. It is expected to significantly strengthen Merck’s Performance Materials business sector.

Versum, an Air Products spin-off, is described as one of the world’s major suppliers of high-purity process chemicals, gases and equipment for semiconductor manufacturing, with sales of $1.4 billion in 2018. It has 2,300 employees at 15 manufacturing and seven R&D facilities in Asia and North America. Merck will maintain the headquarters site at Tempe, Arizona, as the major hub for the combined business in the US.

The two companies had fought a brief war of words after Merck’s initial unsolicited offer. Versum rejected this, saying that it believed Integris’s offer to be better, and refused to engage with Merck. Merck then published an open letter to Versum shareholders, stating that its offer constituted a 51.7% premium to Versum’s pre-announcement price and 17.1% on the value of the Entegris stock they were being offered, and that Versum’s own financial advisor had concluded that the Merck offer was superior.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Axplora's site at Vizag

Axplora expands in India

Axplora has announced a “significant” investment at its site in Vizag, India (pictured)

Submitted by:

Andrew Warmington

Regis' headquarters in Chicago

Esteve acquires Regis

 

Barcelona-based Esteve Química has acquired Regis Technologies, a hitherto privately owned CDMO headquartered in Chicago

Submitted by:

Andrew Warmington

Meribel's facility at Uppsala

Ofichem buys site in Sweden

Netherlands-based CDMO Ofichem has acquired Meribel Pharma Solutions’ former Recipharm site in Uppsala, Sweden, which

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington